Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

31.25USD
19 Oct 2018
Change (% chg)

$0.25 (+0.81%)
Prev Close
$31.00
Open
$31.39
Day's High
$31.50
Day's Low
$29.30
Volume
11,299
Avg. Vol
--
52-wk High
$33.33
52-wk Low
$19.33

Chart for

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

No Ratios Available.

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -- -- --
ROI: -- 0.21 14.27
ROE: -- 1.17 15.99

Earnings vs. Estimates